Pelago Closes $58M to Scale Virtual Clinic for Substance Use Support | StartUp Health Insights: Week of Apr 2, 2024
Pelago was founded on the premise that substance use is a treatable chronic condition. The StartUp Health company is addressing the rising rates and costs of substance misuse head-on through its 100% fees-at-risk model that delivers improved outcomes and demonstrated ROI.
Funders, learn how you can support Health Transformers like the doctorpreneur team at Pelago.
Pelago, a StartUp Health company on a mission to make substance use support available to everyone, raised $58M in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million. The Series C was led by Atomico, with participation from Kinnevik AB, Octopus Ventures, Y Combinator, Eight Roads, and GreyMatter Capital. <source>
Other health innovation funding reported this week included:
Hume AI, a New York, NY-based startup and research lab building AI optimized for human wellbeing, raised $50M led by EQT Ventures, with participation from Union Square Ventures, Nat Friedman & Daniel Gross, Metaplanet, Northwell Holdings, Comcast Ventures, and LG Technology Ventures. <source>
ViaLase, an Aliso Viejo, CA-based clinical-stage medtech company focused on glaucoma treatment, raised $40M led by an undisclosed new investor, with participation from Venture Investors Health Fund, Arboretum Ventures, and Falcon Vision. <source>
Nourish, a New York, NY-based provider of a telenutrition platform that connects people to registered dietitians covered by insurance, raised $35M led by Index Ventures, with participation from Maverick Ventures, TCV, Y Combinator, Thrive Capital, BoxGroup, and angel investors. <source>
Brightside Health, a San Francisco, CA-based telemental health company, raised $33M led by S32, with participation from Kennedy Lewis, Time BioVentures, Anne Wojcicki (Redwood Pacific), ACME, Mousse Partners, and Triventures. <source>
InStride Health, a Boston, MA-based outpatient provider of specialty pediatric anxiety and OCD treatment, raised $30M led by General Catalyst, with participation from .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation. <source>
Intellihealth, a New Canaan, CT-based clinical telehealth platform focused on weight loss, raised $24M from the State of Connecticut and Hearst Corporation’s venture groups, Atlantic Health System, the Venture Collective, and Black Opal Ventures. <source>
EarliTec Diagnostics, a Decatur, GA-based medical device company, raised $21.5M led by Nexus NeuroTech Ventures and Venture Investors Health Fund. <source>
Praia Health, a Seattle, WA-based consumer platform for health systems that aims to innovate the delivery of individualized health solutions at scale, raised $20M led by Frist Cressey Ventures, with participation from SignalFire, Epsilon Health Investors, and Providence Ventures. <source>
Tonic App, a Porto, Portugal-based app that provides doctors with a mobile platform and AI-powered virtual assistant that aggregates all the resources they need to diagnose and treat patients, raised $11.7M (€10.85M) co-led by BlueCrow Capital and Iberis Capital, with participation from Vesalius Biocapital III, Armilar Venture Partners, Portugal Ventures, Shilling VC, and FSNB Health & Care. <source>
Float Health, a San Francisco, CA-based marketplace moving care that doesn’t need a hospital to the home, raised $10M led by Canvas Ventures, with participation from Wave Capital, Y Combinator, Burst Capital, Also Capital, and individual investors. <source>.
Surge, a Paris, France-based company that specializes in high-dimensional immune system analysis combined with AI, raised $8M (€7.5M) led by Eurazeo, with participation from Kima, Teampact, MH Innov’, Boutique Venture, HCVC, and 50 Partners Santé. <source>
Scriptology, a New York, NY-based comprehensive medication management platform, raised $4M through Redesign Health's committed pools of capital. <source>
Wellola, a Dublin, Ireland-based startup that provides the digital communication tools needed to deliver healthcare outside of a hospital setting, raised $2.3M (€2.2M) led by Elkstone, with participation from Enterprise Ireland and Bay Advisory. <source>
Century Health, a New York, NY-based startup applying AI to clinical data to uncover new applications for drugs, raised $2M led by 2048 Ventures, with participation from LifeX, Everywhere, Alumni Ventures, and a group of angel investors. <source>
Goodbill, a Seattle, WA-based startup that verifies that hospital bills are correct, raised $2M led by Founders’ Co-op, Maveron, and Liquid 2 Ventures, with participation from other funds and angels. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Alzheimer’s Innovation
With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, we’ve launched a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. Learn more and apply for an Alzheimer’s Moonshot Fellowship.
Become a Health Moonshot Champion
Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.
Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.